Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
McKinsey
Merck
UBS
Moodys
Teva

Generated: July 23, 2019

DrugPatentWatch Database Preview

Generic Companies with Tentative Approvals for: Prinston Inc

Try a free trialSee Plans and Pricing

« Back to Dashboard

Prinston Inc Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Applicant Generic Name NDA Strength Dosage Form
Prinston Inc hydrochlorothiazide; irbesartan 203072 12.5MG;300MG TABLET;ORAL
Prinston Inc hydrochlorothiazide; irbesartan 203072 25MG/300MG TABLET;ORAL
Prinston Inc hydrochlorothiazide; irbesartan 203072 12.5MG;150MG TABLET;ORAL
Applicant Generic Name NDA Strength Dosage Form

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Fuji
Chinese Patent Office
Teva
Medtronic
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.